Related Experiment Video
Updated: Jun 9, 2025
Evaluation of Respiratory Muscle Activation Using Respiratory Motor Control Assessment RMCA in Individuals with Chronic Spinal Cord Injury
Published on: July 19, 2013
Respiratory Vaccination Rates in People Living With Spinal Cord Injury/Disorder in Switzerland: A Descriptive
Gabi Mueller1, Inge Eriks-Hoogland, Margret Hund-Georgiadis
1From the Swiss Paraplegic Research, Nottwil, Switzerland (GM, MWGB); Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland (GM, IE-H, MWGB); Swiss Paraplegic Centre, Nottwil, Switzerland (IE-H); REHAB Basel, Basel, Switzerland (MH-G); Clinique Romande de Réadaptation, Sion, Switzerland (XJ); Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland (MS); and Corporate Health Consulting, Düdingen, Switzerland (SB); and General practitioner practice, Schenkon, Switzerland (CW).
Objective:
The aim of the study is to provide a population-based evaluation of vaccination coverage to prevent respiratory complications from SARS-COV-2, influenza, and pneumococcus, among community-dwelling persons with spinal cord injury/disease.
Design:
This is a cross-sectional survey conducted in 2022, utilizing questionnaires administered to persons with spinal cord injury/disease living in Switzerland. Main outcomes were ever-vaccination rates for SARS-COV-2, influenza, and pneumococcus. Secondary outcomes included demographics, lesion and education levels, as well as respiratory and cardiovascular conditions. Vaccine hesitancy was additionally assessed for all three vaccines in nonvaccinated persons through questions on reasons for not getting vaccinated.
Results:
A total of 1158 persons participated in this survey. Overall vaccination rates were highest for SARS-COV-2 86.5% (95% CI = 84.4-88.3), followed by influenza 44.6 (41.7-47.6) and pneumococcus: 7.5% (6.0-9.3). The most prominent reasons for not being vaccinated were doubt on effectiveness (72.7%) and potential side effects (60%) for SARS-COV-2, patients did not feel at risk for influenza (57%) and insufficient information from the physician (52.4%) for pneumococcus vaccination.
Conclusions:
In individuals with spinal cord injury/disease, vaccination coverage is notably low for influenza and especially pneumococcus. Vaccine hesitancy varies between vaccination types and is associated with vaccine-specific reasons. These findings underscore the imperative for updated clinical vaccination guidelines, improved public health information, and targeted intervention programs for specific patient groups.
